CRISPR

CRISPR1-plpbp

ID
ZDB-CRISPR-181019-3
Name
CRISPR1-plpbp
Previous Names
None
Target
Sequence
5' - GGTGGAGCGGGTGAATCAAG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
ot101 plpbp
ot102 plpbp
Expression
Gene expression in Wild Types + CRISPR1-plpbp
No data available
Phenotype
Phenotype resulting from CRISPR1-plpbp
No data available
Phenotype of all Fish created by or utilizing CRISPR1-plpbp
Phenotype Fish Conditions Figures
whole organism swimming behavior increased process quality, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 4 from Johnstone et al., 2019
whole organism alpha-aminobutyric acid decreased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
whole organism isoleucine increased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
optic tectum synaptic signaling ictal, ameliorated plpbpot101/+; plpbpot102/+ chemical treatment by environment: pyridoxine Fig. 5 from Johnstone et al., 2019
whole organism 3-aminoisobutyric acid increased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
whole organism beta-alanine increased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
whole organism tyrosine increased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
whole organism dead, ameliorated plpbpot101/+; plpbpot102/+ chemical treatment by environment: pyridoxal 5'-phosphate Fig. 5 from Johnstone et al., 2019
whole organism dead, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 4 from Johnstone et al., 2019
whole organism lysine decreased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
whole organism phenylalanine increased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
whole organism pyridoxal decreased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
whole organism fosab expression increased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 4 from Johnstone et al., 2019
whole organism decreased life span, ameliorated plpbpot101/+; plpbpot102/+ chemical treatment by environment: pyridoxine Fig. 5 from Johnstone et al., 2019
whole organism methionine increased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
whole organism tryptophan increased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
whole organism decreased life span, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 4 from Johnstone et al., 2019
whole organism gamma-aminobutyric acid decreased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
whole organism decreased life span, ameliorated plpbpot101/+; plpbpot102/+ chemical treatment by environment: pyridoxal 5'-phosphate Fig. 5 from Johnstone et al., 2019
brain synaptic signaling ictal, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 4 from Johnstone et al., 2019
whole organism asparagine decreased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
whole organism proline decreased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
whole organism swimming behavior increased process quality, ameliorated plpbpot101/+; plpbpot102/+ chemical treatment by environment: pyridoxine Fig. 5 from Johnstone et al., 2019
whole organism cystathionine increased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
whole organism threonine decreased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
whole organism alanine decreased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
whole organism dead, ameliorated plpbpot101/+; plpbpot102/+ chemical treatment by environment: pyridoxine Fig. 5 from Johnstone et al., 2019
whole organism glutamine decreased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
whole organism pyridoxal 5'-phosphate decreased amount, abnormal plpbpot101/+; plpbpot102/+ standard conditions Fig. 6 from Johnstone et al., 2019
Citations